MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報，我們不為任何個人用途提供產(chǎn)品和服務(wù)。

NGI-1

CAS No. : 790702-57-7

產(chǎn)品活性：NGI-1 (ML414) is a potent oligosaccharyltransferase (OST) inhibitor, directly targeting and blocking the function of the OST catalytic subunits STT3A and STT3B. NGI-1 is a cell permeable inhibitor and can effectively reduce virus infectivity without affecting cell viability.

研究領(lǐng)域：Anti-infection

作用靶點：Virus Protease

In Vitro: NGI-1 inhibits the glycosylation of LASV GP mediated by STT3A-OST (in STT3B- and MAGT1-TUSC3- cells) or STT3B-OST (in STT3A- cells) and impaires its proteolytic cleavage in a dose-dependent manner.
NGI-1 blocks EGFR N-linked glycosylation in lung adenocarcinoma cells as assessed. In controls EGFR is biotinylated, consistent with its plasma membrane expression, but in NGI-1 treated cells the EGFR is predominantly found in the non-biotinylated intracellular fraction suggesting a change in cellular localization.

相關(guān)產(chǎn)品：Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Anti-Cancer Compound Library  |  Antiviral Compound Library  |  Peptidomimetic Library  |  SRPIN340  |  Aminothiazole  |  SP inhibitor 1  |  Genkwanin  |  L-Lysine-¹⁵N₂ (hydrochloride)  |  Aspirin-d₄  |  (-)-α-Pinene  |  2'-Deoxy-2'-fluoro-l-uridine  |  LabMol-319  |  4E2RCat  |  HCVcc-IN-1  |  ZIKV-IN-1  |  HCVcc-IN-2  |  Mpro inhibitor N3  |  ESI-09  |  Tubacin  |  2-Phenylethanol-d₉  |  L-Lysine-¹³C₆ (dihydrochloride)  |  Phenytoin  |  ML188  |  N-Desmethylclozapine  |  DENV-IN-8  |  ZIKV-IN-3  |  Encephalitic alphavirus-IN-1  |  Plerixafor octahydrochloride  |  4-Phenylbutyric acid-d₁₁  |  SID-852843  |  NS2B/NS3-IN-3  |  (-)-Epicatechin gallate

熱門產(chǎn)品線：重組蛋白  |  化合物庫  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物  |  寡核苷酸  |  抗體  |  點擊化學(xué)

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫，我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng)；
•   產(chǎn)品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產(chǎn)品，廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學(xué)分析檢測分析，藥物篩選等專業(yè)技術(shù)服務(wù)；
•   設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告，確保產(chǎn)品的高純度、高品質(zhì)；
•   產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業(yè)團(tuán)隊跟蹤最新的制藥及生命科學(xué)研究進(jìn)展，為您提供全球新的活性化合物；
•   與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長期的合作。